Example: Heart Attack

Clinical Trials Sponsored by Velindre NHS Trust

Total 21 results

    • NCT03935672
      Not yet recruiting
      PEARL PET-based Adaptive Radiotherapy Clinical Trial
      Conditions: Oropharyngeal Cancer
    • NCT02530411
      Unknown status
      Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast Cancer
      Conditions: Neoplasms
    • NCT02465424
      Completed
      Assessing Quality of Life Tools in Medullary Thyroid Cancer Patients
      Conditions: Medullary Thyroid Cancer
    • NCT01992952
      Active, not recruiting
      Fulvestrant +/- Akt Inhibition in Advanced Aromatase Inhibitor Resistant Breast Cancer
      Conditions: Estrogen Receptor Positive Breast Cancer
    • NCT01774279
      Recruiting
      interNational Anaplastic Thyroid Cancer Tissue Bank and Database (iNATT)
      Conditions: Anaplastic Thyroid Cancer
    • NCT00519805
      Unknown status
      Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
      Conditions: Lung Cancer; Thromboembolism
    • NCT00182715
      Unknown status
      Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer
      Conditions: Colorectal Cancer
    • NCT02953197
      Completed
      18F-FDG-PET Guided Dose-Painting With Intensity Modulated Radiotherapy in Oropharyngeal Tumours
      Conditions: Oropharyngeal Cancer
    • NCT00326820
      Unknown status
      Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
      Conditions: Breast Cancer; Hypercalcemia of Malignancy; Metastatic Cancer
    • NCT02741856
      Recruiting
      Study of Chemoradiotherapy in Oesophageal Cancer Including PET Response and Dose Escalation
      Conditions: Oesophageal Cancer
    • NCT02215265
      Recruiting
      Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
      Conditions: Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer
    • NCT01915693
      Completed
      ROCS (Radiotherapy After Oesophageal Cancer Stenting) Study
      Conditions: Oesophageal Cancer
    • NCT01843829
      Unknown status
      A Feasibility Study of Chemo-radiotherapy to Treat Operable Oesophageal Cancer
      Conditions: Oesophageal Cancer
    • NCT01788332
      Unknown status
      Parp Inhibitor in Advanced Non-Small Cell Lung Cancer (PIN)
      Conditions: Non-small Cell Lung Cancer
    • NCT01537991
      Completed
      ISoToxic Accelerated RadioTherapy in Locally Advanced Non-small Cell Lung Cancer: The Phase I/II I-START Trial
      Conditions: Locally Advanced Non-small Cell Lung Cancer
    • NCT01569919
      Unknown status
      A Phase II Trial to Assess TroVax® Plus Chemotherapy in Patients With Malignant Pleural Mesothelioma
      Conditions: Malignant; Pleural; Mesothelioma
    • NCT03644303
      Recruiting
      Targeted Radiotherapy in Androgen-suppressed Prostate Cancer Patients.
      Conditions: Prostate Cancer; Metastasis; Toxicity Due to Radiotherapy; Circulating Tumour DNA
    • NCT02510001
      Unknown status
      MEK and MET Inhibition in Colorectal Cancer
      Conditions: Solid Tumor; Colorectal Cancer
    • NCT03994653
      Recruiting
      Cancer Loyalty Card Study
      Conditions: Ovarian Neoplasms
    • NCT04550104
      Not yet recruiting
      A Platform Study of Novel Agents in Combination With Radiotherapy in NSCLC
      Conditions: Non Small Cell Lung Cancer
    • NCT02344927
      Completed
      CRT Hydration in the Last Days of Life (Feasibility Study)
      Conditions: Cancer
      Medical Conditions
      Sponsors and Collaborators
      Drug Interventions
      Conditions
      Rare Diseases
      Drug Interventions
      Dietary Supplements
      Sponsor/Collaborators
      Locations